Dr. Mark Lebwohl, MD, is the Waldman Chair of Dermatology at the Icahn School of Medicine at Mount Sinai. He earned his medical degree from Harvard Medical School in Boston and completed residencies in both internal medicine and dermatology at Mount Sinai.  

 

Dr. Lebwohl is a recipient of numerous awards, including Lifetime Achievement Awards by the National Psoriasis Foundation and by the American Skin Association. The professional positions he has held in the past and at present include: President of the American Academy of Dermatology, Chairman of the Psoriasis Task Force of the American Academy of Dermatology, Chair of the Medical Board of the National Psoriasis Foundation, President of New York State Society of Dermatology, President of the Manhattan Dermatologic Society,  President of the Dermatology Section of the New York Academy of Medicine.  

 

Dr. Lebwohl is actively involved in clinical trials and is the lead principal investigator for clinical trials of major drugs, such as the 1st IL-17, Cosentyx (secukinumab, Novartis) that has reached the annual net sales of $2.8 billion in 2018 since its approval in 2015.  

 

Dr. Lebwohl has chaired numerous symposia, has delivered many honorary lectures around the world, and has written, edited, or coedited several books, including the first atlas devoted entirely to cutaneous manifestations of systemic disease and the leading book on dermatologic therapy, "Treatment of Skin Disease."  

 

His books have been translated into French, Portuguese, Chinese, Spanish and Polish. Other books written or co-written by Dr. Lebwohl include "Difficult Diagnoses in Dermatology," "Psoriasis," "Mild-to-Moderate Psoriasis," and "Moderate-to-Severe Psoriasis." He is the founding editor of the medical journal Psoriasis Forum and has served as medical editor for the National Psoriasis Foundation member magazine, Psoriasis Advance. Dr. Lebwohl is on the editorial board of the Journal of the American Academy of Dermatology and is editor of the Dermatology Section of Scientific American Medicine, now called ACP Medicine.  

 

Dr. Lebwohl has authored or co-authored more than 500 publications, including peer-reviewed articles, invited articles, and book chapters.